Camber parent Hetero honored for hepatitis C efforts
PISCATAWAY, N.J. — Hetero Drugs, the India-based parent company of Camber Pharmaceuticals, has been honored by Gilead Sciences its commitment to providing access to life-saving medications for chronic hepatitis C patients around the world. Camber said Wednesday that the award from Gilead — a leader in the development of hepatitis C drugs — recognizes Hetero’s